ArticleBMC gastroenterology2026
Differentiating walled-off pancreatic necrosis with no documented pancreatitis from mucinous cystic neoplasms: a multicenter LASSO-based nomogram.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesThis study aimed to investigate the clinical characteristics and imaging features of walled-off pancreatic necrosis (WOPNs) involving the pancreatic parenchyma in patients with no documented pancreatitis, and to establish a diagnostic prediction nomogram using Lasso regression to differentiate WOPNs from mucinous cystic neoplasms (MCNs).
methodsA total of 247 cases were retrospectively collected from three independent hospitals, including surgically confirmed post-inflammatory necrotic collections meeting imaging criteria for WOPNs and pathologically confirmed MCNs. Clinical and imaging features were analyzed, and independent predictors were identified using Lasso regression. Clinical, imaging, and combined diagnostic models were constructed and assessed using ROC, calibration, and decision curve analyses (DCA). A diagnostic nomogram was developed from the best model.
resultsUnivariate analysis revealed significant differences between WOPNs and MCNs in the training cohort for age, sex, clinical symptoms, lesion location, shape, lesion margin, cyst category, incomplete septation, peripancreatic fat space, density/signal, cyst wall and/or septal thickness, mural nodule, lesion calcification, peripancreatic inflammatory changes, MPD morphology, location of ductal dilation, vascular involvement, and organ involvement (p < 0.05). Lasso regression identified three clinical features, eight imaging features, and five combined clinical and imaging features as independent risk factors, which were subsequently used to construct clinical, imaging, and combined models. The combined model achieved the highest diagnostic performance, with AUC values of 0.880 in the training cohort and 0.858 and 0.856 in the two external validation cohorts, respectively, demonstrating good sensitivity, specificity, and overall accuracy.
conclusionWe established a reliable, non-invasive diagnostic prediction nomogram based on Lasso regression to differentiate WOPNs with no documented pancreatitis from MCNs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.